Merger & Acquisition Update Verana Health, a real-world data (RWD) analytics firm, has announced the acquisition of oncology specialist COTA Healthcare for $52 million. This merger creates a major player in the digital health space, boasting a comprehensive data repository designed to accelerate pharmaceutical research and development.
Strategic Key Facts:
-
Expanding Therapeutic Reach: By integrating COTA, Verana Health officially extends its expertise into oncology. Previously, Verana’s core strengths were concentrated in ophthalmology, urology, and neurology.
-
Massive Data Scale: The combined entity now holds access to the health records of over 95 million patients and a contributing network of more than 20,000 clinicians.
-
Market Position: The merged firm currently serves 17 of the world’s top 20 biopharmaceutical companies. The acquisition was funded by equity investments from existing backers, including Google Ventures.
-
AI and Machine Learning Integration: Verana utilizes artificial intelligence to curate real-world data, assisting drug developers in optimizing clinical trial designs and accelerating patient recruitment.
-
Strategic Objective: Combining Verana’s advanced curation technology with COTA’s deep oncology insights aims to meet the rising demand for high-quality real-world evidence (RWE) in approving and monitoring the efficacy of new treatment protocols.
Source: https://www.bioxconomy.com/clinical-and-research/untitled